Proton MR Spectroscopy of Polymicrogyria and Heterotopia

References

1. ↵
   Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB. Classification system for malformations of cortical development: update 2001. Neurology 2001;57:2168–2178

   Abstract/FREE Full Text
2. ↵
   Barkovich JA. Pediatric Neuroimaging. 3rd ed. Philadelphia: Lippincott Williams and Wilkins;2000 :283–317
3. ↵
   Mukonoweshuro W, Wilkinson ID, Griffiths PD. Proton MR spectroscopy of cortical tubers in adults with tuberous sclerosis complex. AJNR Am J Neuroradiol 2001;22:1920–1925

   Abstract/FREE Full Text
4. ↵
   Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49–58

   Abstract/FREE Full Text
5. ↵
   Fulham MJ, Dietz MJ, Duyn JH, Shih HH, Alge JR, Di Chiro G. Transsynaptic reduction of N-acetyl-L-aspartate in cerebellar diaschisis: a proton MR spectroscopic imaging study. J Comput Assist Tomogr 1994;18:697–704

   PubMedWeb of Science
6. ↵
   Castillo M, Kwock L. Proton MR spectroscopy of common brain tumours. Neuroimaging Clin N Am 1998;8:733–752

   PubMed
7. ↵
   Ricci PE. Proton MR spectroscopy in ischaemic stroke and other vascular disorders. Neuroimaging Clin N Am 1998;8:881–900

   PubMedWeb of Science
8. ↵
   Hida K, Kwee IL, Nakada T. In vivo 1H and 31P NMR spectroscopy of the developing rat brain. Magn Reson Med 1992;23:31–36

   PubMed
9. ↵
   Christiansen P, Henriksen O, Stubgaard M, Gideon P, Larsson HBW. In vivo quantification of brain metabolites by 1H-MRS using water as internal standard. Magn Reson Imaging 1993;11:107–118

   CrossRefPubMedWeb of Science
10. ↵
    Petroff OAC, Plebam LA, Spencer DD. Symbiosis between in vivo and in vitro nuclear magnetic resonance spectroscopy: the creatine, N-acetyl aspartate, glutamate, and GABA content of epileptic human brain. Magn Reson Imaging 1995;13:1197–1211

    CrossRefPubMedWeb of Science
11. ↵
    Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatinine, and choline. NMR Biomed 1991;4:47–52

    PubMedWeb of Science
12. ↵
    Miller BL, Chang L, Booth R, et al. In vivo 1H-MRS choline: correlation with in vitro chemistry/histology. Life Sci 1996;58:1929–1935

    CrossRefPubMedWeb of Science
13. ↵
    Sener RN. Infantile tuberous sclerosis changes in the brain: proton MR spectroscopy findings. Comput Med Imag Graph 2000;24:19–24

    CrossRefPubMed
14. ↵
    Battaglia G, Arcelli P, Granata T, et al. Neuronal migration disorders and epilepsy: a morphological analysis of three surgically treated patients. Epilepsy Res 1996;26:49–58

    CrossRefPubMedWeb of Science
15. ↵
    Lee N, Radtke RA, Gray L, et al. Neuronal migration disorders: positron emission tomography correlations. Ann Neurol 1994;35:290–297

    CrossRefPubMedWeb of Science
16. ↵
    Castillo M, Kwock L, Murkherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1–15

    PubMedWeb of Science
17. ↵
    Kuzniecky R, Hetherington H, Pan J, et al. Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy. Neurology 1997;48:1018–1024

    Abstract/FREE Full Text
18. ↵
    Kaminaga T, Kobayashi M, Abe T. Proton magnetic resonance spectroscopy in disturbances of cortical development. Neuroradiology 2001;43:575–580

    CrossRefPubMed
19. ↵
    Li LM, Cendes F, Bastos AC. Neuronal metabolic dysfunction in patients with cortical developmental malformations. Neurology 1998;50:755–759

    Abstract/FREE Full Text
20. ↵
    Simone IL, Federico F, Tortorella C, et al. Metabolic changes in neuronal migration disorders: evaluation by combined MRI and proton MR spectroscopy. Epilepsia 1999;40:872–879

    CrossRefPubMedWeb of Science
21. ↵
    Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonanace spectroscopy. Magn Reson Med 1993;30:424–437

    CrossRefPubMedWeb of Science
22. ↵
    Hashimoto T, Tayama M, Miyazaki M, et al. Developmental brain changes investigated with proton magnetic resonance spectroscopy. Dev Med Child Neurol 1995;37:398–405

    PubMedWeb of Science
23. ↵
    Van der Knaap MS, Van der Grond J, Van Rijen PC, Faber JA, Valk J, Willemse K. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 1990;176:509–515

    PubMedWeb of Science
24. ↵
    Tedeschi G, Bertolino A, Righini A, et al. Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology 1995;45:1384–1391

    Abstract/FREE Full Text
25. ↵
    Hetherington HP, Mason GF, Pan JW, et al. Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T. Magn Reson Med 1994;32:565–571

    PubMedWeb of Science
26. ↵
    Hanstock CC, Rothman DL, Prichard JW, Jue T, Shulman RG. Spatially localized ¹H NMR spectra of metabolites in the human. Proc Natl Acad Sci USA 1988;85:1821–1825

    Abstract/FREE Full Text